2022
DOI: 10.1097/01.hs9.0000848048.13001.58
|View full text |Cite
|
Sign up to set email alerts
|

P1296: Suppressing Synthesis of the Long Isoform of the Prolactin Receptor Is a Targeted Strategy to Treat Autoimmune B-Lymphoproliferative Diseases and B Cell Malignancies

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles